MarketCap
Vir Biotechnology VIR
€ 9.88
5.05%
Facebook
X
Telegram
Vir Biotechnology EV | VIR
EV Jährlich Vir Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.02 B | 1.03 B | 1.68 B | 2.92 B | 5.61 B | 2.96 B | 693 M | 323 M | 132 M | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.61 B | 132 M | 1.82 B |
EV anderer Aktien in der Pharmaeinzelhändler
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Jaguar Health
JAGX
|
57 M | $ 2.36 | 15.44 % | $ 5.5 M |  USA |
 |
Protalix BioTherapeutics
PLX
|
193 M | $ 2.49 | -2.35 % | $ 196 M |  Israel |
 |
uniQure N.V.
QURE
|
1.17 B | $ 21.65 | -3.5 % | $ 1.24 B |  Niderland |
 |
Stoke Therapeutics
STOK
|
1.99 B | $ 25.41 | 1.48 % | $ 1.5 B | USA |
 |
Xencor
XNCR
|
1.08 B | $ 29.2 | 15.95 % | $ 2.17 B | USA |
 |
Annexon
ANNX
|
673 M | $ 3.71 | -1.2 % | $ 575 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
-721 K | $ 1.71 | -4.21 % | $ 2.82 M | Israel |
 |
Incyte Corporation
INCY
|
18.2 B | $ 113.3 | -2.08 % | $ 22.1 B | USA |
 |
Mesoblast Limited
MESO
|
25.7 M | $ 12.43 | 1.22 % | $ 15 B |  Australia |
 |
MeiraGTx Holdings plc
MGTX
|
835 M | $ 9.2 | -0.16 % | $ 740 M | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
127 B | $ 516.39 | -1.44 % | $ 132 B | USA |
 |
Burford Capital Limited
BUR
|
5.73 B | $ 3.24 | -3.72 % | $ 710 M |  Britain |
 |
Catalyst Biosciences
CBIO
|
986 M | $ 12.77 | -0.39 % | $ 1.14 B | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.92 B | $ 25.47 | 1.29 % | $ 1.19 B | USA |
 |
Anika Therapeutics
ANIK
|
156 M | $ 21.19 | -1.07 % | $ 304 M | USA |
 |
Editas Medicine
EDIT
|
218 M | $ 2.4 | 0.05 % | $ 213 M | USA |
 |
Evogene Ltd.
EVGN
|
1.49 M | $ 0.37 | 0.44 % | $ 2.91 M | Israel |
 |
EyePoint Pharmaceuticals
EYPT
|
-42.8 M | $ 0.36 | -10.09 % | $ 26.4 K | USA |
 |
Fortress Biotech
FBIO
|
122 M | $ 1.87 | -3.11 % | $ 52.2 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
167 M | $ 10.12 | 0.4 % | $ 289 M | USA |
 |
Foghorn Therapeutics
FHTX
|
582 M | $ 2.04 | 2.0 % | $ 128 M | USA |
 |
Dr. Reddy's Laboratories Limited
RDY
|
153 B | $ 13.76 | 4.13 % | $ 11.5 B |  India |
 |
Arcturus Therapeutics Holdings
ARCT
|
43.4 M | $ 9.91 | 0.71 % | $ 271 M | Israel |
 |
Sanofi
SNY
|
51.6 B | $ 41.77 | 0.41 % | $ 51 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
3.64 B | $ 31.74 | 1.73 % | $ 4.04 B | USA |
 |
Geron Corporation
GERN
|
1.33 B | $ 1.15 | 2.23 % | $ 767 M | USA |
 |
Gossamer Bio
GOSS
|
365 M | $ 9.2 | -4.27 % | $ 2.1 B | USA |
 |
Titan Pharmaceuticals
TTNP
|
-2.35 M | - | -3.76 % | $ 3.47 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
11.9 M | - | 3.16 % | $ 1.9 M | USA |
 |
ALX Oncology Holdings
ALXO
|
131 M | $ 1.14 | -2.56 % | $ 61.2 M | USA |
 |
Heron Therapeutics
HRTX
|
411 M | $ 0.3 | -0.46 % | $ 50 M | USA |
 |
Achieve Life Sciences
ACHV
|
126 M | $ 6.55 | 0.85 % | $ 286 M | USA |
 |
TCR2 Therapeutics
TCRR
|
92.6 M | - | - | $ 58.1 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
1.95 B | $ 17.02 | 0.98 % | $ 2.29 B |  Canada |
 |
iBio
IBIO
|
98.5 M | $ 0.71 | -1.28 % | $ 73.9 M | USA |
 |
ImmuCell Corporation
ICCC
|
69.7 M | $ 10.21 | -0.37 % | $ 92.2 M | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
4.14 B | $ 84.95 | 0.13 % | $ 7.99 B | USA |
 |
Inhibikase Therapeutics
IKT
|
-10.3 M | $ 1.51 | -5.03 % | $ 148 M | USA |
 |
Immunome
IMNM
|
1.28 B | $ 17.89 | -0.54 % | $ 1.56 B | USA |
|
TFF Pharmaceuticals
TFFP
|
7.83 M | - | -60.05 % | $ 125 K | USA |
 |
InMed Pharmaceuticals
INM
|
5.21 M | $ 1.57 | 9.03 % | $ 6.54 M | Canada |
 |
Inovio Pharmaceuticals
INO
|
104 M | $ 0.88 | -1.82 % | $ 41.3 M | USA |
 |
Innoviva
INVA
|
1.07 B | $ 21.06 | 1.91 % | $ 1.42 B | USA |
 |
Iovance Biotherapeutics
IOVA
|
52.9 M | $ 13.78 | -2.24 % | $ 4.92 M | USA |
 |
Theratechnologies
THTX
|
62.7 M | - | - | $ 83.9 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
143 M | - | -15.15 % | $ 60.3 M | Britain |
 |
AVEO Pharmaceuticals
AVEO
|
111 M | - | - | $ 521 M | USA |
 |
Axon Enterprise
AXON
|
33.2 B | $ 424.81 | 1.06 % | $ 33.2 B | USA |
 |
Axcella Health
AXLA
|
22.6 M | - | -16.42 % | $ 249 M | USA |
 |
Keros Therapeutics
KROS
|
261 M | $ 11.35 | 0.62 % | $ 422 M | USA |